| Table 5. Number (%) of centers routinely performing diagnostic tests on their clinical staff or patients before the start of ovarian stimulation. | ||||||
| Patients with positive symptoms or COVID 19 diagnostic test | July | Aug n=179 |
Sept n=144 | Oct n=110 |
Nov n=138 |
Dec n=98 |
|---|---|---|---|---|---|---|
| No cases | 132 (73.7) | 91 (63.2) | 52 (47.3) | 55 (39.9) | 33 (33.7) | |
| Positive cases | 47 (26.3) | 53 (36.8) | 58 (52.7) | 83 (60.1) | 65 (66.3) | |
| Proportions of affected
patients 1-2% 3-5% 6-10% >11% |
28 (15.6) 9 (5.0) 7 (3.9) 3 (1.7) |
30 (20.8) 15 (10.4) 8 (5.6) 0 |
32 (29.1) 14 (12.7) 11 (10.0) 1 (0.9) |
50 (36.2) 22 (15.9) 10 (7.2) 1 (0.7) |
33 (33.7) 24 (24.5) 6 (6.1) 2 (2.0) |
|